share_log

【SEC Form 4/A修正】ORGANICELL REGENERATIVE MEDICINE IN(OCEL.US)首席执行官增持104.95万股普通股股份,价值约1.04万美元

(SEC Amendment) ORGANICELL REGENERATIVE MEDICINE IN(OCEL.US) Officer Buys US$10,439.56 in Common Stocks

Futu News ·  Dec 22, 2023 05:39

$ORGANICELL REGENERATIVE MEDICINE IN (OCEL.US)$ Officer Leider Harry L. purchased 1.05 million shares of Common Stocks on Jun 28, 29, 2023 at an average price of $0.0099 for a total value of $10,439.56.

1703194799667703436.png

What is statement of changes in beneficial ownership of securities?

It is a requirement under federal securities laws that mandates individuals, including officers, directors, and those who hold more than 10% of any class of a company's securities (collectively known as "insiders"), to report their purchases, sales, and holdings of their company's securities by submitting Forms 3, 4, and 5.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment